Anusha Madadi, MD
Hematology & Oncology · Fayetteville, NCNPI 1447416334
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $43,688 of the $57,195 with a category attached, or 76.4%. 25 manufacturers reported payments, led by AstraZeneca at 24.5% of the total. Among hematology & oncology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $583.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$14K
- Incyte Corporation$10K
- Acceleron Pharma, Inc.$7K
- Bristol Myers Squibb$7K
- Kyowa Kirin, Inc.$4K
- Avyxa Pharma, LLC$4K
- plus $11K from 19 others
Across 3 payments — averaging $4042.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$12K
What the payments were for
- Consulting fees$43,68876%
- Speaking & faculty fees$5,78010%
- Travel & lodging$6,02011%
- Food & beverage$1,6293%
- Education$790%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $13,996 |
| Incyte Corporation | 21 | $10,170 |
| Acceleron Pharma, Inc. | 3 | $7,250 |
| Bristol Myers Squibb | 7 | $6,983 |
| Kyowa Kirin, Inc. | 10 | $4,162 |
| Avyxa Pharma, LLC | 7 | $3,710 |
| Exelixis Inc. | 1 | $1,980 |
| Johnson & Johnson | 6 | $1,911 |
| Beigene USA, Inc. | 1 | $1,650 |
| Gilead | 2 | $1,012 |
| Immunomedics, Inc. | 1 | $1,000 |
| Beigene, Ltd. | 2 | $975 |
| Astellas Pharma US Inc | 1 | $500 |
| EMD Serono, Inc. | 1 | $500 |
| GSK | 1 | $450 |
| Sanofi | 9 | $273 |
| Daiichi Sankyo Inc. | 1 | $200 |
| Novocure GmbH | 1 | $200 |
| Athenex Pharmaceutical Division, LLC | 1 | $175 |
| Lilly USA, LLC | 1 | $21 |
| Novartis | 1 | $18 |
| Genentech, Inc. | 1 | $18 |
| Roche Diagnostics Corporation | 1 | $18 |
| Epizyme, Inc. | 1 | $12 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$57,195 in reported general payments places this provider in the 90th percentile of 358 hematology & oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 80 | $37,209 |
| Abiraterone Acetate | 41 | $23,180 |
| Hydroxyurea | 50 | $1,390 |
| Imatinib Mesylate | 12 | $869 |
| Acyclovir | 36 | $823 |
| Anastrozole | 51 | $773 |
| Ondansetron Hcl | 42 | $525 |
| Dexamethasone | 14 | $331 |
| Prochlorperazine Maleate | 20 | $240 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $179 |
| Prednisone | 24 | $157 |
| Folic Acid | 11 | $39 |
| Tramadol Hcl | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Fayetteville
- Tariq NazirFayetteville$78K
- Amit MehtaCary$4.3M
- Michael MorseDurham$2.6M
- Shelbi AtrashCharlotte$994K
- Phillip FebboDurham$749K
- Angela AlistarWinston Salem$509K
- Ravi PaluriWinston Salem$314K
- Matthew McKinneyDurham$277K
- Jared WeissChapel Hill$217K
- Joshua ZeidnerChapel Hill$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.